[1] |
LIN Yi, WANG Ce, KANG Xun, KANG Zhuang, CHEN Feng, JIANG Bo, LI Wenbin.
Screening recurrent glioblastoma-related genes and analyzing their gene expressions in association with clinicopathological parameters and prognosis
[J]. China Oncology, 2022, 32(1): 13-23.
|
[2] |
JIN Yizi, LIN Mingxi, ZHANG Jian.
Targeting DNA damage response deficiency in the treatment of breast cancer
[J]. China Oncology, 2022, 32(1): 61-67.
|
[3] |
LI Zeng , WU Yi , CHEN Zhuzhong , CHEN Li , LIAO Hong , MAO Dun , XIAO Yingming , XIE Hongping , LI Xiuli , YANG Shengke , ZHOU Shukui , ZHONG Lei , LU Hao , CHEN Yongji .
The value of 18 F-PSMA-1007 PET/CT in the early diagnosis and clinical treatment of patients with biochemical recurrence after radical prostatectomy
[J]. China Oncology, 2021, 31(11): 1081-1087.
|
[4] |
CHEN Shaogeng, HE Rongqi, ZHANG Wanfei, LIN Xianzuan, CHEN Heshan, XU Rongyu.
miR-122-5p inhibits the growth of esophageal cancer cells and transplanted tumors by targeting CREB1
[J]. China Oncology, 2021, 31(1): 35-44.
|
[5] |
BI Zhao , SONG Xianrang , CHEN Peng , XIE Li , JIANG Wei , SONG Xingguo , CONG Binbin , WANG Yongsheng .
A study of neutrophil to lymphocyte ratio for the prediction of axillary pathological complete response after neoadjuvant therapy in breast cancer
[J]. China Oncology, 2021, 31(1): 63-68.
|
[6] |
LU Xiaoteng, XU Qing.
A study on factors associated with recurrence of non-small cell lung cancer based on CT image features
[J]. China Oncology, 2020, 30(8): 636-640.
|
[7] |
CHEN Yang , LIU Wei , LI Ruimin , WANG Qifeng , SHEN Xigang , TANG Wei .
Radiogenomics: association between BI-RADS mammographic imaging features and the 21-gene recurrence score
[J]. China Oncology, 2020, 30(7): 505-511.
|
[8] |
FENG Zheng, WU Xiaohua.
Hematological toxicities of maintenance PARP inhibitors for patients with platinum-sensitive recurrent ovarian cancer
[J]. China Oncology, 2020, 30(4): 299-304.
|
[9] |
LI Min, WEN Peng, QIAN Qiuqin, QIN Ang, ZENG Li, SHI Feng.
Clinical study of iodine-125 seeds implantation in the treatment of lymph node metastasis of radioactive iodine- refractory differentiated thyroid cancer
[J]. China Oncology, 2020, 30(2): 122-127.
|
[10] |
YANG Ke, ZHENG Rong, LIN Yansong.
The interpretation of management guidelines for children with thyroid nodules and differentiated thyroid cancer: radioactive iodine therapy and new progress
[J]. China Oncology, 2019, 29(6): 401-411.
|
[11] |
ZHANG Liyang, LIU Chunhao, CAO Yue, LIU Hongfeng, GAO Weisheng, LI Xiaoyi.
Experiences of 125 cases of re-operated persistent/recurrent differentiated thyroid cancer
[J]. China Oncology, 2019, 29(6): 412-417.
|
[12] |
GAO Luying, LIN Yansong, JIANG Yuxin, LI Jianchu, LI Hui, ZHANG Bo, LIU Ruyu, XI Xuehua, GAO Qiong, WANG Ying, ZHAO Ruina.
Evaluation of short-term efficacy of apatinib using cervical ultrasound and thyroglobulin in the treatment of progressive radioactive iodine-refractory differentiated thyroid cancer
[J]. China Oncology, 2019, 29(6): 418-422.
|
[13] |
LU Chenghui, LI Jiao, LIU Xinfeng, WANG Guoqiang, WANG Zenghua, WANG Xufu.
Clinical outcome after 131I treatment in differentiated thyroid cancer with negative stimulated thyroglobulin and lymph node metastasis
[J]. China Oncology, 2019, 29(6): 429-433.
|
[14] |
LIU Shan, FANG Juan, WANG Lili, ZHANG Yinghong, DU Wenjie, ZHU Taohua.
Association between peripheral nerve invasion and recurrence risk factors in cervical cancer
[J]. China Oncology, 2019, 29(6): 439-444.
|
[15] |
ZHENG Weizhen, SUN Jujie, LIU Yanbing, QIU Pengfei, BI Zhao, ZHAO Tong, WANG Yongsheng.
Validation and modification study of axillary node pathologic complete response predictive model after neoadjuvant chemotherapy for breast cancer
[J]. China Oncology, 2019, 29(6): 445-451.
|